SARTF
Price
$211.46
Change
+$4.61 (+2.23%)
Updated
Oct 16 closing price
Capitalization
16.7B
Intraday Buy/Sell Signals
WAT
Price
$334.59
Change
-$0.28 (-0.08%)
Updated
Oct 17 closing price
Capitalization
19.92B
16 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

SARTF vs WAT

Header iconSARTF vs WAT Comparison
Open Charts SARTF vs WATBanner chart's image
Sartorius AG
Price$211.46
Change+$4.61 (+2.23%)
Volume$78
Capitalization16.7B
Waters
Price$334.59
Change-$0.28 (-0.08%)
Volume$446.6K
Capitalization19.92B
SARTF vs WAT Comparison Chart in %
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SARTF vs. WAT commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SARTF is a Hold and WAT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (SARTF: $211.46 vs. WAT: $334.59)
Brand notoriety: SARTF and WAT are both not notable
SARTF represents the Pharmaceuticals: Other, while WAT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SARTF: 297% vs. WAT: 67%
Market capitalization -- SARTF: $16.7B vs. WAT: $19.92B
SARTF [@Pharmaceuticals: Other] is valued at $16.7B. WAT’s [@Medical Specialties] market capitalization is $19.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $159.93B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.18B. The average market capitalization across the [@Medical Specialties] industry is $11.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SARTF’s FA Score shows that 0 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • SARTF’s FA Score: 0 green, 5 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, WAT is a better buy in the long-term than SARTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SARTF’s TA Score shows that 3 TA indicator(s) are bullish while WAT’s TA Score has 6 bullish TA indicator(s).

  • SARTF’s TA Score: 3 bullish, 3 bearish.
  • WAT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than SARTF.

Price Growth

SARTF (@Pharmaceuticals: Other) experienced а -0.75% price change this week, while WAT (@Medical Specialties) price change was +1.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.29%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +14.72%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.25%. For the same industry, the average monthly price growth was +3.05%, and the average quarterly price growth was +51.76%.

Reported Earning Dates

WAT is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.29% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAT($19.9B) has a higher market cap than SARTF($16.7B). SARTF has higher P/E ratio than WAT: SARTF (94.08) vs WAT (30.17). SARTF YTD gains are higher at: 14.925 vs. WAT (-9.809). WAT has higher annual earnings (EBITDA): 1.06B vs. SARTF (844M). SARTF has more cash in the bank: 872M vs. WAT (367M). WAT has less debt than SARTF: WAT (1.54B) vs SARTF (4.66B). SARTF has higher revenues than WAT: SARTF (3.47B) vs WAT (3.05B).
SARTFWATSARTF / WAT
Capitalization16.7B19.9B84%
EBITDA844M1.06B80%
Gain YTD14.925-9.809-152%
P/E Ratio94.0830.17312%
Revenue3.47B3.05B114%
Total Cash872M367M238%
Total Debt4.66B1.54B303%
FUNDAMENTALS RATINGS
SARTF vs WAT: Fundamental Ratings
SARTF
WAT
OUTLOOK RATING
1..100
8817
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10054
SMR RATING
1..100
8725
PRICE GROWTH RATING
1..100
4648
P/E GROWTH RATING
1..100
9170
SEASONALITY SCORE
1..100
2890

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SARTF's Valuation (76) in the null industry is in the same range as WAT (87) in the Medical Specialties industry. This means that SARTF’s stock grew similarly to WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (54) in the Medical Specialties industry is somewhat better than the same rating for SARTF (100) in the null industry. This means that WAT’s stock grew somewhat faster than SARTF’s over the last 12 months.

WAT's SMR Rating (25) in the Medical Specialties industry is somewhat better than the same rating for SARTF (87) in the null industry. This means that WAT’s stock grew somewhat faster than SARTF’s over the last 12 months.

SARTF's Price Growth Rating (46) in the null industry is in the same range as WAT (48) in the Medical Specialties industry. This means that SARTF’s stock grew similarly to WAT’s over the last 12 months.

WAT's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as SARTF (91) in the null industry. This means that WAT’s stock grew similarly to SARTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SARTFWAT
RSI
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
66%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
57%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USOI47.710.05
+0.11%
UBS ETRACS Crude Oil Shares Cov Cll ETN
EQRR62.33N/A
N/A
ProShares Equities for Rising Rates ETF
ARB28.90N/A
N/A
AltShares Merger Arbitrage ETF
PUSH50.47-0.01
-0.01%
PGIM Ultra Short Municipal Bond ETF
IBDW21.29-0.05
-0.23%
iShares iBonds Dec 2031 Term Corp ETF

SARTF and

Correlation & Price change

A.I.dvisor tells us that SARTF and SOAGY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SARTF and SOAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SOAGY - SARTF
25%
Poorly correlated
+1.69%
RVTY - SARTF
25%
Poorly correlated
-0.54%
SRTOY - SARTF
24%
Poorly correlated
-1.57%
EXAS - SARTF
24%
Poorly correlated
-0.10%
WAT - SARTF
21%
Poorly correlated
-0.08%
More